Cognitive Function and Health-related Quality of Life After Neuro-intensive Care (COGNI)

November 3, 2022 updated by: Kirsten Moller, Rigshospitalet, Denmark

Cognitive Function and Health-related Quality of Life After Neuro-intensive Care: An Observational Multicenter Cohort Study

The study will provide information on cognitive impairment and Health related quality of life in patients surviving 12 months after acute brain injury, generate a hypothesis of useful variables to predict cognitive impairment or low levels of HRQoL, and potentially inform interventions for the prevention and treatment of cognitive impairment following neuro-ICU stay.

Study Overview

Detailed Description

The aim is to 1) measure the frequency and extent of cognitive impairment after acute brain injury at six and 12-months after neuro-Intensive care unit (ICU) admission 2) explore the association between cognitive impairment at six and 12 months after ICU admission with the following potential risk factors: duration of ICU delirium (days), duration of sepsis (days), duration of post traumatic amnesia (days) and the severity of brain injury (initial Glasgow Coma Scale , 3) describe Health related quality of life, functional disability and frailty at six and 12 after ICU admission and 4) explore the association between the functional disability, frailty and health-related quality of life at 12 months after ICU admission

Study Type

Observational

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 110 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adults with acute brain injury from traumatic brain injury, spontaneous intracranial hemorrhage, or ischemic stroke with a Neuro ICU stay

Description

Inclusion Criteria:

  • Traumatic brain injury
  • Spontaneous intracranial hemorrhage
  • Ischemic stroke
  • An anticipated stay in the neuro-ICU for 48 hours or longer.

Exclusion Criteria:

  • Persistent coma defined as Richmond Agitation-Sedation Scale (RASS) -5 to -3 throughout the neuro-ICU stay
  • Congenital brain injury
  • Suspected pre-existing Cognitive impairment (Informant Questionnaire on cognitive decline in the elderly (IQCODE): 3.3 or more) (regardless of cause)
  • Permanent residence outside Denmark
  • Inability to communicate in Danish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Global cognitive function
Time Frame: from baseline to 6 months after ICU admission
measured by The Repeatable Battery for the Assessment of Neuropsychological Status, Overall score (mean 100; SD=15). Higher scores indicate better cognitive functioning.
from baseline to 6 months after ICU admission
Change in Global cognitive function
Time Frame: from baseline to 12 months after ICU admission
measured by The Repeatable Battery for the Assessment of Neuropsychological Status, Overall score (mean 100; SD=15). Higher scores indicate better cognitive functioning.
from baseline to 12 months after ICU admission
Change in Executive function
Time Frame: from baseline to 6 months after ICU admission
measured by Trail Making Test B, Score indicate time in seconds to complete task, the higher speed (less seconds) indicates higher executive function
from baseline to 6 months after ICU admission
Change in Executive function
Time Frame: from baseline to 12 months after ICU admission
measured by Trail Making Test B, Score indicate time in seconds to complete task, the higher speed (less seconds) indicates higher executive function
from baseline to 12 months after ICU admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Health related quality of life after brain injury
Time Frame: from baseline to 6 months after ICU admission
measured with a disease specific questionnaire:Quality of Life after Brain Injury overall scale (QOLIBRI-OS). Scores are from 0-100, the higher the score the more quality of life.
from baseline to 6 months after ICU admission
Change in Health related quality of life after brain injury
Time Frame: from baseline to 12 months after ICU admission
measured with a disease specific questionnaire:Quality of Life after Brain Injury overall scale (QOLIBRI-OS). Scores are from 0-100, the higher the score the more quality of life.
from baseline to 12 months after ICU admission
Delirium
Time Frame: during the procedure (ICU stay) up to 30 days
measured by Confusion measured by CAM-ICU or Intensive Care Delirium Screening Checklist (ICDSC).
during the procedure (ICU stay) up to 30 days
Change in Disability after head injury/nontraumatic acute brain insults I
Time Frame: from baseline to 6 months after ICU admission
measured by Glasgow outcome scale extended (GOSE). Scores from 1 to 8, higher scores indicate less disability
from baseline to 6 months after ICU admission
Change in Disability after head injury/nontraumatic acute brain insults I
Time Frame: from baseline to 12 months after ICU admission
measured by Glasgow outcome scale extended (GOSE). Scores from 1 to 8, higher scores indicate less disability
from baseline to 12 months after ICU admission
Change in Disability after head injury/nontraumatic acute brain insults II
Time Frame: from baseline to 6 months after ICU admission
measured by Extended disability rating scale (DRS). Scores from 0 to 29, the higher the score the more disability
from baseline to 6 months after ICU admission
Change in Disability after head injury/nontraumatic acute brain insults II
Time Frame: from baseline to 12 months after ICU admission
measured by Extended disability rating scale (DRS). Scores from 0 to 29, the higher the score the more disability
from baseline to 12 months after ICU admission
Change in Frailty
Time Frame: baseline to 6 months after ICU admission
measured by the Clinical Frailty Scale (CFS). Scale is from 1 to 9 ( the higher score the more frail).
baseline to 6 months after ICU admission
Change in Frailty
Time Frame: baseline to 12 months after ICU admission
measured by the Clinical Frailty Scale (CFS). Scale is from 1 to 9 ( the higher score the more frail).
baseline to 12 months after ICU admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Suzanne F Herling, Ph.D, Rigshospitalet, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 1, 2021

Primary Completion (Anticipated)

August 1, 2024

Study Completion (Anticipated)

August 1, 2025

Study Registration Dates

First Submitted

April 22, 2021

First Submitted That Met QC Criteria

May 5, 2021

First Posted (Actual)

May 11, 2021

Study Record Updates

Last Update Posted (Actual)

November 8, 2022

Last Update Submitted That Met QC Criteria

November 3, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

Clinical Trials on no intervention

3
Subscribe